Hank F. Kung

¹⁸F Stilbenes and Styrylpyridines for PET Imaging of Aβ Plaques in Alzheimer’s Disease: A Miniperspective

Hank F. Kung, Seok Choi, Wenchao Qü et al. · Journal of Medicinal Chemistry · 2009 · 195 citations · Full text

Medicine, Neurology, Nuclear Medicine +17

In vitro and in vivo evaluation of [123I]IBZM: a potential CNS D-2 dopamine receptor imaging agent.

Hank F. Kung, Sangren Pan, Mei‐Ping Kung et al. · PubMed · 1989 · 164 citations

Medicine, Neuroscience, Pharmacology +15

Safety, biodistribution, and dosimetry of 123I-IMPY: a novel amyloid plaque-imaging agent for the diagnosis of Alzheimer's disease.

Andrew B. Newberg, Nancy Wintering, John Hochold et al. · PubMed · 2006 · 144 citations

Medicine, Nuclear Medicine, Pharmacology +17

Relationship between clinical features of Parkinson's disease and presynaptic dopamine transporter binding assessed with [123I]IPT and single-photon emission tomography

Klaus Tatsch, Johannes Schwarz, P. David Mozley et al. · European Journal of Nuclear Medicine and Molecular Imaging · 1997 · 135 citations

Life Sciences, Neurology, Neuroscience +16

Noninvasive quantification of dopamine D2 receptors with iodine-123-IBF SPECT.

Masanori Ichise, James R. Ballinger, Haim Golan et al. · PubMed · 1996 · 133 citations

Medicine, Nuclear Medicine, Pharmacology +15